Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
Recent Findings
NIDA Genetics Programs
 
Return to Home Page
About Genetics Workgroup
Human Genetics Application Guidelines
NIDA Genetics News
NIDA Genetics Consortium
NIDA Recent Findings
NIDA Genetics Portfolio
NIDA Initiatives in Genetics
NIDA Meetings
NIDA Program Contacts
 

Resources for Genetics, Cell Biology, and Neuroscience
 
Calendar
Human Genetics
Tissue and Cell Repositories
Twin Registry
Nucleotide
Gene Expression
Genomes
Proteins
Model Organisms
Mouse
Knowledgebase for Addiction Related Genes (KARG)
Cell Biology
SfN Neuroscience Database
Gateway
Bibliographic Resources
 

2004 - 2005 Publications > Genetics of Cannabinoid System

Genetics of Cannabinoid System

  • Chiang et al at Scripps show the first evidence that a natural genetic polymorphism P129T in the human FAAH gene associated with problem drug use produces a mutant enzyme with defective biochemical and cellular properties.  Human Mol. Genetics, 13:2113, 2004.)
  • Zhang et al report association between CB1/Cnr1 haplotypes and substance abuse phenotypes. Mol Psychiatry. 2004 Oct;9(10):916-31
  • Soria showed SR141716A-precipitated THC withdrawal and the rewarding effects of THC are signicantly reduced in Adenosine A2 receptor knockout mice   Eur J Neurosci. 2004 Oct;20(8):2203-13.
  • Fatty acid amide hydrolase (FAAH) in activates anandamide, an endogenous cannabinoid.  The FAAH 385 A/A missense polymorphism is associated with obesity in American with European and African ancestry but not with Asian ancestry.  These results suggest that the endocannabinoid system plays a role in regulating body weight.  Sipe et al. Int J Obes (Lond). 2005 Jul;29(7):755-9.
  • Comorbidity between cannabis dependence and depression largely due to shared genetic and environmental vulnerabilities predisposing to both outcomes. Lynskey et al Arch General Psychiatry, 2004, 61: 1026-32
  • Jo et al found that endocannabinoid signaling functions with leptin to modulate feeding behavior.  Neuron. 2005 Dec 22;48(6):1055-66
  • Kreitzer and Malenka (Stanford U Med Sch)    Found  that dopamine regulates long term synaptic plasticity in the dorsal striatum (brain structure important for reinforcement learning) via endogenous cannabinoids J Neurosci. 2005 Nov 9;25(45):10537-45
  • Van Sickle et al Identified CB2 cannabinoid receptor mRNA and functional protein in central nervous system neurons Science. 2005 Oct 14;310(5746):329-32
 
 
 
 
Any questions or concerns regarding the genetics programs please contact Jonathan D. Pollock Ph.D. (301) 443-1887 or jp183r@nih.gov


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Thursday, September 4, 2008. The U.S. government's official web portal